Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:462 (21 February), doi:10.1136/bmj.328.7437.462-a
| The first 150 words of the full text of this article appear below. |
EDITORFlorin and Dixon bring coherence and clarity to what has hitherto been a muddled debate.1 Two things are worth adding.
Firstly, the more devolved and local public involvement in health policy development becomes the more the government's national strategy and targets become givens. The public was not involved in the British government's decision to focus on mortality and cure (which are easily measurable) at the expense of long term medical conditions that chiefly affect the quality of people's lives. But that focus has become a given that will dominate the development of local health policy. If governments wish to provide the sort of health care people want, public involvement in health strategy development is needed at the highest level.
Secondly, a tendency prevails to see public involvement as something separate from the rest of health policy development instead of an integral part of it. Dermatology is an exception.
Peter M Lapsley, chief executive
Skin Care Campaign, London N19 5NA peter.lapsley@btopenworld.com